Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Maschmeyer

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study groupDiana Wongso, Michael Fuchs, Annette Plütschow, et al.
Annals of Hematology|April 8, 2021
Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)William H Krüger, Carsten Hirt, Nadezda Basara, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipientsCatherine Cordonnier, Simone Cesaro, Georg Maschmeyer, et al.
International Journal of Antimicrobial Agents|August 25, 2009
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registryJörg J Vehreschild, Michal Sieniawski, Stefan Reuter, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipientsAlexandre Alanio, Philippe M Hauser, Katrien Lagrou, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipientsJohan Maertens, Simone Cesaro, Georg Maschmeyer, et al.
Annals of Hematology|June 25, 2016
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Andrew J Ullmann, Martin Schmidt-Hieber, Hartmut Bertz, et al.
European Journal of Haematology|June 2, 2012
Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samplesMark Reinwald, Birgit Spiess, Werner J Heinz, et al.
Annals of Hematology|June 22, 2014
Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyDaniela Tacke, Dieter Buchheidt, Meinolf Karthaus, et al.
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study groupDiana Wongso, Michael Fuchs, Annette Plütschow, et al.
Annals of Hematology|April 8, 2021
Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)William H Krüger, Carsten Hirt, Nadezda Basara, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipientsCatherine Cordonnier, Simone Cesaro, Georg Maschmeyer, et al.
International Journal of Antimicrobial Agents|August 25, 2009
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registryJörg J Vehreschild, Michal Sieniawski, Stefan Reuter, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipientsAlexandre Alanio, Philippe M Hauser, Katrien Lagrou, et al.
The Journal of Antimicrobial Chemotherapy|August 24, 2016
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipientsJohan Maertens, Simone Cesaro, Georg Maschmeyer, et al.
Annals of Hematology|June 25, 2016
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Andrew J Ullmann, Martin Schmidt-Hieber, Hartmut Bertz, et al.
European Journal of Haematology|June 2, 2012
Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samplesMark Reinwald, Birgit Spiess, Werner J Heinz, et al.
Annals of Hematology|June 22, 2014
Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and OncologyDaniela Tacke, Dieter Buchheidt, Meinolf Karthaus, et al.
Haematologica|August 24, 2011
Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patientsMaria J G T Vehreschild, Arne M K Meissner, Oliver Andreas Cornely, et al.
Pageof 10